» Articles » PMID: 24393152

The Use of Dermal Substitutes in Burn Surgery: Acute Phase

Overview
Date 2014 Jan 8
PMID 24393152
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Major burns represent a challenge in autologous skin coverage and may lead to severe functional and cosmetic sequelae. Dermal substitutes are increasingly becoming an essential part of burn care during the acute phase of treatment. In the long term dermal substitutes improve functional and cosmetic results and thus enhance quality of life. In the chronic wound setting, dermal substitutes are used to reconstruct and improve burn scars and defects. Despite the potential of dermal substitutes, further research is required to strengthen scientific evidence regarding their effects and also to develop new technologies and products. Furthermore, dermal substitutes have a pivotal role in future research strategies as they have the potential to provide adequate scaffold for stem cells, tissue engineering, and regenerative medicine with conceivable application of obtaining long-lasting and scarless artificial skin. This review discusses the status quo of dermal substitutes and novel strategies in the use of dermal substitutes with a focus on burn care.

Citing Articles

Advancements in bioengineered and autologous skin grafting techniques for skin reconstruction: a comprehensive review.

Dean J, Hoch C, Wollenberg B, Navidzadeh J, Maheta B, Mandava A Front Bioeng Biotechnol. 2025; 12():1461328.

PMID: 39840132 PMC: 11747595. DOI: 10.3389/fbioe.2024.1461328.


Indications for the use of dermal substitutes in patients with acute burns and in reconstructive surgery after burns: A systematic review.

van den Bosch A, Verwilligen R, Pijpe A, Jansen L, van der Vlies C, van Eck M Wound Repair Regen. 2024; 33(1):e13248.

PMID: 39727218 PMC: 11672668. DOI: 10.1111/wrr.13248.


Efficacy and Complications Associated with Acellular Dermal Substitute Use in the Treatment of Acute Burns: A Systematic Review and Meta-Analysis.

Press I, Moiemen N, Ahmed Z Eur Burn J. 2024; 4(4):548-562.

PMID: 39600025 PMC: 11571822. DOI: 10.3390/ebj4040036.


Advancements in 3D skin bioprinting: processes, bioinks, applications and sensor integration.

Derman I, Rivera T, Garriga Cerda L, Singh Y, Saini S, Abaci H Int J Extrem Manuf. 2024; 7(1):012009.

PMID: 39569402 PMC: 11574952. DOI: 10.1088/2631-7990/ad878c.


Use of Dermal Substrate for the Treatment of Pediatric Deep Partial-Thickness Burns.

Bergus K, Schwartz D, Patterson K, Srinivas S, Fabia R, Thakkar R Eplasty. 2024; 24:e54.

PMID: 39473999 PMC: 11520366.


References
1.
Wainwright D . Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns. 1995; 21(4):243-8. DOI: 10.1016/0305-4179(95)93866-i. View

2.
Yannas I, Burke J, Gordon P, Huang C, Rubenstein R . Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res. 1980; 14(2):107-32. DOI: 10.1002/jbm.820140203. View

3.
Phillips T . Biologic skin substitutes. J Dermatol Surg Oncol. 1993; 19(8):794-800. DOI: 10.1111/j.1524-4725.1993.tb00426.x. View

4.
Andreadis S, Hamoen K, Yarmush M, Morgan J . Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 2001; 15(6):898-906. DOI: 10.1096/fj.00-0324com. View

5.
Muangman P, Engrav L, Heimbach D, Harunari N, Honari S, Gibran N . Complex wound management utilizing an artificial dermal matrix. Ann Plast Surg. 2006; 57(2):199-202. DOI: 10.1097/01.sap.0000218636.61803.d6. View